Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9296108 | 0.87 | — | — | |
| SCHEMBL6273596 | 0.85 | — | — | |
| SCHEMBL10932944 | 0.83 | — | — | |
| SCHEMBL87710 | 0.79 | — | — | |
| SCHEMBL30605 | 0.77 | TSHR (0.38) | LPAR2LPAR3ALDH1A1 | |
| SCHEMBL31694471 | 0.74 | BTN3A1 (0.36) | — | |
| SCHEMBL3507987 | 0.74 | CYP3A4 (0.32) | LPAR2LPAR3ALDH1A1 | |
| SCHEMBL9570202 | 0.74 | LPAR2 (0.32) | LPAR2LPAR3ALDH1A1 | |
| SCHEMBL14061859 | 0.74 | MAPT (0.31) | — | |
| SCHEMBL10384660 | 0.74 | ALDH1A1 (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399208-A1 | IRAK INHIBITOR FOR TREATING CYTOKINE RELEASE-RELATED CONDITIONS ASSOCIATED WITH INFECTION BY A RESPIRATORY VIRUS | Rigel Pharmaceuticals, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| CN-114686574-B | Method and kit for detecting nucleotide large fragment deletion | 厦门大学 | 2024-07-02 | — | — | CN | claimed |
| US-11788118-B2 | Method for detecting target nucleic acid sequences | XIAMEN ZEESAN BIOTECH CO., LTD. (CN) | 2023-10-17 | — | — | US | claimed |
| CN-111100862-B | Method for detecting bacterial serotypes | 厦门大学 | 2023-09-29 | — | — | CN | claimed |
| US-20230303555-A1 | PYRIMID-2-YL-PYRAZOLE COMPOUNDS AS IRAK INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | US | claimed |
| WO-2023183377-A1 | PYRIMID-2-YL-PYRAZOLE COMPOUNDS AS IRAK INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| WO-2023038815-A1 | IRAK INHIBITOR FOR TREATING CYTOKINE RELEASE-RELATED CONDITIONS ASSOCIATED WITH INFECTION BY A RESPIRATORY VIRUS | RIGEL PHARMACEUTICALS, INC. (US) | 2023-03-16 | — | — | WO | claimed |
| EP-3640340-B1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | XIAMEN ZEESAN BIOTECH CO LTD (CN) | 2022-06-29 | — | — | EP | claimed |
| EP-4003990-A1 | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS | Rigel Pharmaceuticals, Inc. (US) | 2022-06-01 | — | — | EP | claimed |
| CN-114364674-A | Pyrazole compounds, formulations thereof, and methods of using the compounds and/or formulations | 里格尔药品股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| WO-2021041898-A1 | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS | RIGEL PHARMACEUTICALS, INC. (US) | 2021-03-04 | — | — | WO | claimed |
| US-20210061798-A1 | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS | RIGEL PHARMACEUTICALS, INC. (US) | 2021-03-04 | — | — | US | claimed |
| US-20200140931-A1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | XIAMEN ZEESAN BIOTECH CO., LTD. (CN) | 2020-05-07 | — | — | US | claimed |
| EP-3640340-A1 | METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCES | Xiamen University (CN) | 2020-04-22 | — | — | EP | claimed |
| EP-2344447-A2 | GABA CONJUGATES AND METHODS OF USE THEREOF | Kyphia Pharmaceuticals, Inc. (US) | 2011-07-20 | — | — | EP | claimed |
| WO-2010042759-A2 | GABA CONJUGATES AND METHODS OF USE THEREOF | KYPHIA PHARMACEUTICALS INC (US) | 2010-04-15 | — | — | WO | claimed |
| US-7667033-B2 | Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis | SYNGEN, INC. (US) | 2010-02-23 | — | — | US | claimed |
| US-20090171076-A1 | COMPOSITIONS AND METHODS FOR THE USE OF FMOC DERIVATIVES IN DNA/RNA SYNTHESIS | SYNGEN, INC. | 2009-07-02 | — | — | US | claimed |
| US-20080098643-A1 | Ethanol modifier and its application | HOU JINPENG | 2008-05-01 | — | — | US | claimed |
| US-20070179289-A1 | Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis | SYNGEN, INC. | 2007-08-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061798-A1 | PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS | IRAK1, IRAK3, IRAK2 | LPAR2 4059/4885LPAR3 3298/4885ALDH1A1 3780/4885 |
| US-20230303555-A1 | PYRIMID-2-YL-PYRAZOLE COMPOUNDS AS IRAK INHIBITORS | IRAK2, IRAK3, IRAK1 | LPAR2 1354/4885LPAR3 1581/4885ALDH1A1 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.